Northwestern has formed the Center for Translational Pain Research, which aims to advance basic and clinical science in the hopes of developing non-addictive treatments for chronic pain.
A drug originally designed to help manage diabetes may also improve quality of life for patients with heart failure, according to a recent clinical trial.
A new study published in JAMA found neladenoson bialanate did not improve exercise capacity among patients suffering from heart failure with preserved ejection fraction.
Daily vitamin D supplements did not significantly reduce the risk of Type 2 diabetes among adults at high risk for the disease, according to a large clinical trial published in The New England Journal of Medicine.
Cholesterol levels in U.S. youth have improved from 1999 to 2016, but only half of children and adolescents are in the ideal range, according to a new study published in JAMA.
Waiting to begin treatments for diabetic macular edema until patients experience vision loss resulted in similar outcomes compared to starting treatments prior to vision loss, according to a recent study published in JAMA.
Northwestern scientists have identified a new function for a transcription factor called BCL6, finding that it switches off genes involved in lipid metabolism.
Northwestern Medicine scientists discovered how circadian rhythm regulates hunger, a long-suspected connection that was identified in a study published in Cell Metabolism
Gentle noise stimulation synchronized with an individual’s brainwaves boosted cardiovascular health, according to a recent study.
Increased consumption of eggs and dietary cholesterol is linked to a significantly higher risk of cardiovascular disease and death, according to a new study.